Despite the potential of digital health and innovative therapies to revolutionize healthcare, adoption and development remain complex challenges. What is the current state of the regulatory and reimbursement pathways for digital health and medicine? What to expect from the EHDS? What initiatives are underway to promote interoperability, data sharing and access to secondary use of health data? Have reimbursement processes like DiGA or PECAN proved their effectiveness in deploying digital health solutions? What are the key components of successful value proposition and revenue model for digital health innovations? How do investment strategies of VCs and big players influence the development and adoption of digital health technologies? How can further collaboration between healthcare providers, regulators, industry, and patients accelerate their adoption?
- 11:15 am
- - 12:30 pm
